These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2985046)

  • 21. Enzymic product formation curves with the normal or diffusion limited reaction mechanism and in the presence of substrate receptors.
    Chrastil J
    Int J Biochem; 1988; 20(7):683-93. PubMed ID: 2846380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-competitive inhibition by active site binders.
    Blat Y
    Chem Biol Drug Des; 2010 Jun; 75(6):535-40. PubMed ID: 20374252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advantages of continuous over batch reactors for the kinetic analysis of enzymes inhibited by an unknown substrate impurity.
    Gallifuoco A; Alfani F; Cantarella M
    Biotechnol Bioeng; 2002 Sep; 79(6):641-6. PubMed ID: 12209811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of enzyme kinetic parameters and differentiation between various mechanisms by means of a non-linear least squares method].
    Haerlin R; Steinijans V
    Arzneimittelforschung; 1978; 28(2):292-7. PubMed ID: 580396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Convenient method for studying enzyme kinetics.
    Hsu TA; Tsao GT
    Biotechnol Bioeng; 1979 Dec; 21(12):2235-46. PubMed ID: 117848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competitive irreversible inhibition of enzymes in the presence of a substrate: scope and limitations.
    Kovach IM
    J Enzyme Inhib; 1991; 4(3):201-12. PubMed ID: 2037866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway.
    Rausch S; Hänchen A; Denisiuk A; Löhken M; Schneider T; Süssmuth RD
    Chembiochem; 2011 May; 12(8):1171-3. PubMed ID: 21538763
    [No Abstract]   [Full Text] [Related]  

  • 28. Enzyme inhibition in open systems. Superiority of uncompetitive agents.
    Westley AM; Westley J
    J Biol Chem; 1996 Mar; 271(10):5347-52. PubMed ID: 8621387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generalized theoretical and practical treatment of the kinetics of an enzyme-catalyzed reaction in the presence of an enzyme equimolar irreversible inhibitor.
    Golicnik M; Stojan J
    J Chem Inf Comput Sci; 2003; 43(5):1486-93. PubMed ID: 14502482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction between full and partial inhibitors acting on a single enzyme. A theoretical analysis.
    Palatini P
    Mol Pharmacol; 1983 Jul; 24(1):30-41. PubMed ID: 6865924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of slow-binding enzyme inhibitors at elevated enzyme concentrations.
    Perdicakis B; Montgomery HJ; Guillemette JG; Jervis E
    Anal Biochem; 2005 Feb; 337(2):211-23. PubMed ID: 15691501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The origin and use of the terms competitive and non-competitive in interactions among chemical substances in biological systems.
    McIlwain H
    Essays Biochem; 1986; 22():158-86. PubMed ID: 3030738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzyme specificity: its meaning in the general case.
    Cornish-Bowden A
    J Theor Biol; 1984 Jun; 108(3):451-7. PubMed ID: 6748701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new plot for multiple enzyme inhibition.
    Palatini P
    Biochem Int; 1983 Aug; 7(2):247-53. PubMed ID: 6383391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data.
    Cortés A; Cascante M; Cárdenas ML; Cornish-Bowden A
    Biochem J; 2001 Jul; 357(Pt 1):263-8. PubMed ID: 11415458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition and activation of enzymes. The effect of a modifier on the reaction rate and on kinetic parameters.
    Fontes R; Ribeiro JM; Sillero A
    Acta Biochim Pol; 2000; 47(1):233-57. PubMed ID: 10961698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Identification of mechanism of enzyme/transport process in the system of "enzyme/ transporter--substrate--effector" using the "ratio" method].
    Karakhim SO; Horchev VF; Kosterin SO
    Ukr Biokhim Zh (1999); 2007; 79(2):97-113. PubMed ID: 18030757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INAKT--an interactive non-linear regression program for enzyme inactivation and affinity labelling studies.
    Christophersen A; McKinley-McKee JS
    Int J Biomed Comput; 1984; 15(1):61-8. PubMed ID: 6546558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A microscopic model of enzyme kinetics.
    Gentry R; Ye L; Nemerson Y
    Biophys J; 1995 Aug; 69(2):356-61. PubMed ID: 8527648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
    Chang TK; Chen J; Lee WB
    J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.